obesity Obesity Management
Conditions
Interventions
This is a longitudinal, controlled, randomized, double-blind study. The experimental group will receive spirulina supplementation, while the control group will receive a placebo, both without knowledg
Sponsors
Universidade de Cuiaba Unic
Universidade Federal do Mato Grosso- UFMT
Eligibility
Sex/Gender
Female
Age
30 Years to 50 Years
Inclusion criteria
Inclusion criteria: Obese women (grades I, II, III); between 30 and 50 years old; who are not using weight-loss medication; do not have external nutritional monitoring; and do not engage in regular physical activity
Exclusion criteria
Exclusion criteria: Women outside the defined age range who are using weight-loss medication or under the nutritional supervision of another professional; and those who practice physical activity; men in any condition; also women with comorbidities such as neuropathies; acute deep vein thrombosis; psychiatric disorders and/or dementia without speech or comprehension of the English language; pregnant women; and those who refuse to sign the informed consent form
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| It is expected that spirulina supplementation will modulate weight control in obese women resulting in a 10% reduction in total body mass | — |
Secondary
| Measure | Time frame |
|---|---|
| It is expected that spirulina supplementation will modulate the inflammatory profile reducing these markers to normal levels and improving cardiovascular balance by reducing resting heart rate in obese women | — |
Countries
BR
Contacts
Public ContactAndrea Galvão
Universidade de Cuiaba Unic
Outcome results
None listed